Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Ficus carica leaf
Feuilles de figuier commun utilisées dans la médecine populaire des traditions méditerranéennes, moyen-orientales et sud-asiatiques pour le diabète et les affections cutanées.
Fig leaf (Ficus carica) is used in Mediterranean, Middle Eastern, and South Asian folk medicine primarily for its antidiabetic and topical dermatological applications. Its key active compounds include ficusin (psoralen), flavonoids, and phenolic acids, which contribute to hypoglycemic, antifungal, and anti-inflammatory effects. Evidence is limited (Grade C) but supports traditional uses for diabetes and skin conditions.
The antidiabetic effect is attributed to inhibition of α-glucosidase and α-amylase enzymes, reducing postprandial hyperglycemia, along with enhanced insulin secretion and sensitivity via activation of PPAR-γ and AMPK pathways. Topical activity involves psoralen-mediated photosensitization, which increases melanocyte activity and suppresses fungal growth through DNA intercalation and reactive oxygen species generation. Anti-inflammatory actions are linked to flavonoid inhibition of COX-2 and NF-κB signaling.
Feuilles de figuier commun utilisées dans la médecine populaire des traditions méditerranéennes, moyen-orientales et sud-asiatiques pour le diabète et les affections cutanées.
Fig leaf (Ficus carica) is used in Mediterranean, Middle Eastern, and South Asian folk medicine primarily for its antidiabetic and topical dermatological applications. Its key active compounds include ficusin (psoralen), flavonoids, and phenolic acids, which contribute to hypoglycemic, antifungal, and anti-inflammatory effects. Evidence is limited (Grade C) but supports traditional uses for diabetes and skin conditions.
The antidiabetic effect is attributed to inhibition of α-glucosidase and α-amylase enzymes, reducing postprandial hyperglycemia, along with enhanced insulin secretion and sensitivity via activation of PPAR-γ and AMPK pathways. Topical activity involves psoralen-mediated photosensitization, which increases melanocyte activity and suppresses fungal growth through DNA intercalation and reactive oxygen species generation. Anti-inflammatory actions are linked to flavonoid inhibition of COX-2 and NF-κB signaling.